Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Coronary Stents Market Overview
The coronary stents market size was valued at $5.03 billion in 2023 and will grow at a CAGR of less than 1% during 2023-2033. Factors such as rapidly changing lifestyles and unhealthy diets are leading to increased risk of coronary heart disease, which will drive the market growth in coming years.
A coronary stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The coronary stent system consists of a stent and balloon catheter delivery system.
Coronary Stents Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Coronary Stents Market Forecast, Download a Free Report Sample
The coronary stents market research report identifies quantitative market trends within cardiovascular devices therapeutic areas. The report offers regional quantitative and qualitative data, highlighting the sales in major markets. The model also provides an in-depth discussion of COVID-19’s effects on the coronary stents market for 2020 and beyond. Furthermore, the report provides coronary stents market share by company that will help in identifying untapped market opportunities.
Market Size (2023) | $5.03 billion |
CAGR (2023-2033) | <1% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Regions |
|
Key Segments | · Coronary Bare Metal Stents (BMS)
· Coronary Drug Eluting Stents · Coronary Covered Stents · Coronary Bioabsorbable Stents |
Leading Companies | · Boston Scientific Corp
· Abbott Laboratories · Medtronic Plc · Biotronik SE & Co KG · Lepu Medical Technology (Beijing) Co Ltd · B. Braun Melsungen AG |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Coronary Stents Market Segments
The Coronary Stents Market is segmented into Coronary Bare Metal Stents (BMS), Coronary Drug Eluting Stents (DES), Coronary Covered Stents, and Coronary Bioabsorbable Stents (BAS). The DES segment accounted for the largest market share in 2023. The volume of DES devices used is increasing globally due to their superior clinical outcomes compared to other stents.
Coronary drug-eluting stents release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.
Coronary bioabsorbable stents are also known as bioresorbable or biodegradable coronary stents. They are made from the material found in dissolvable sutures known as polylactic acid. The advantage of coronary bioabsorbable stents is that it does not leave any metal body behind, and hence the possibility of late-stent thrombosis and restenosis decreases.
Coronary Stents Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights into the Coronary Stents Market Segments, Download a Free Report Sample
Regional Analysis of Coronary Stents Market
The key regions in the coronary stents market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. In 2023, the North American coronary stents market was the leading regional segment.
The North American coronary stents market growth is attributed to high demand for DES devices, which are used in more than 95% of PCI cases. The US and Canada will see stable growth in the coronary stent market during the forecast period. Due to a rise in the aging population, the burden of CHD remains high. Additionally, better PCI techniques and tools will allow physicians to treat patients with PCI, thereby increasing the demand for stents.
The US coronary stents market follows regional trends for North America. Factors such as the rising aging population, the reduced need for repeat intervention, and investment in R&D will drive the stenting procedure volume in the US in the coming years.
Coronary Stents Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Coronary Stents Market, Download A Free Report Sample
Coronary Stents Market – Competitive Landscape
In 2023, Boston coronary stents market share was the highest
A few of the leading companies in the coronary stents market are:
- Boston Scientific Corp
- Abbott Laboratories
- Medtronic Plc
- Biotronik SE & Co KG
- Lepu Medical Technology (Beijing) Co Ltd
- Braun Melsungen AG
To penetrate the market, small companies should develop a generation of bioabsorbable stents that show superior clinical results. The potentially successful smaller companies would make good acquisition targets for large companies looking to enter the bioabsorbable stent market.
Coronary Stents Market Analysis by Companies, 2023 (%)
Buy the Full Report to Know More About the Leading Companies In the Coronary Stents Market, Download A Free Report Sample
Coronary Stents Market Dynamics
Drivers: Changing lifestyles, unhealthy diets, and rapid globalization will drive the coronary stents market growth during the forecast period. However, factors such as the high cost of treatment and post-procedural complications of stenting may challenge the market growth.
Future Outlook: Most developed countries have recognized the effectiveness of PCI and stenting procedures to treat AP and MI. The penetration rate for PCI procedures is high, which implies that much of the population that requires treatment is being treated with PCI leading to slower growth. Furthermore, developing countries have potential owing to the presence of a large undiagnosed and untreated population.
Buy the Full Report to Know More About the Coronary Stents Market Dynamics, Download a Free Report Sample
Segments Covered in the Report
Coronary Stents Segments Outlook (Value, $ Billion, 2015-2033)
- Coronary Bare Metal Stents
- Coronary Drug Eluting Stents
- Coronary Covered Stents
- Coronary Bioabsorbable Stents
Coronary Stents Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Key Inclusions of the market model are:
The coronary stents market research report includes an insightful review of the key industry trends.
- The coronary stents market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global coronary stents market insights:
- The coronary stents market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Coronary stents market SWOT analysis.
- The report provides trends and Coronary stents market competitive dynamics.
Buy the Full Report to Know More About the Coronary Stents Market Share, Download a Free Report Sample
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies Covered: Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina GmbH, Vascular Concepts Ltd, and Others.
Countries Covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the coronary stents market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the coronary stents market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on coronary stents.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving coronary stents.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of coronary stents market share by company. Identify strong competitors and create winning strategies to stand out in the global coronary stents market.
- Track regional coronary stents market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global coronary stents market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
Abbott Laboratories
Medtronic Plc
Biotronik SE & Co KG
Lepu Medical Technology (Beijing) Co Ltd
B. Braun Melsungen AG
MicroPort Scientific Corp
Sahajanand Medical Technologies Pvt Ltd
Meril Life Sciences Pvt Ltd
Translumina Therapeutics LLP
Vascular Concepts Ltd
Others
Frequently asked questions
-
What was the coronary stents market size in 2023?
The coronary stents market size was valued at $5.03 billion in 2023.
-
Which region held the highest share of the coronary stents market in 2023?
In 2023, the North American coronary stents market was the leading regional segment.
-
Which segment accounted for the largest share of the coronary stents market in 2022?
The coronary drug-eluting stents segment accounted for the highest share of the market and will continue to drive growth throughout the forecast period.
-
Which are the major players operating in the coronary stents market?
A few of the leading companies in the Coronary Stents market are Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, and Lepu Medical Technology (Beijing) Co Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.